Table 1 Clinical characteristics in non-survival and survival groups
Characteristics | Total | Condition at discharge | p-value | |
|---|---|---|---|---|
No-survival | Survival | |||
Age (mean (SD)) years1/ | 51,73 (12,40) | 58,07 (11,02) | 48,37 (11,8) | 0,000* |
Gender (n (%))2/ | ||||
Male | 146 (71,22) | 56 (38,36) | 90 (61,64) | 0,078 |
Female | 59 (28,78) | 15 (25,42) | 44 (74,58) | |
T2DM (%))2/ | ||||
Yes | 28 (13,66) | 11 (39,29) | 17 (60,71) | 0,578 |
No | 177 (86,34) | 60 (33,9) | 117 (66,1) | |
HBP (n (%))2/ | ||||
Yes | 34 (16,59) | 15 (44,12) | 19 (55,88) | 0,203 |
No | 171 (83,41) | 56 (32,75) | 115 (67,25) | |
Obesity (n (%))2/ | ||||
Yes | 54 (26,34) | 15 (27,78) | 39 (72,22) | 0,217 |
No | 151 (73,66) | 56 (37,09) | 95 (62,91) | |
BMI (mean (SD))3/ | 29,66 (4,54) | 29,04 (4,78) | 30,01 (4,38) | 0,060 |
APACHE II at admission (mean (SD))3/ | 17,24 (6,04) | 18,79 (6,47) | 16,42 (5,66) | 0,010* |
SOFA (mean (SD))3/ | ||||
24 h | 7,55 (2,93) | 8,45 (3,33) | 7,07 (2,57) | 0,006* |
48 h | 5,93 (2,65) | 6,83 (2,87) | 5,48 (2,42) | 0,002* |
72 h | 5,18 (2,71) | 6,47 (2,9) | 4,56 (2,39) | 0,000* |
Corticosteroids use (n (%))2/ | 183 (89,27) | 63 (34,43) | 120 (65,57) | 0,857 |
Heparin use (n (%))2/ | 161 (78,92) | 59 (36,65) | 102 (63,35) | 0,175 |
Hospitalization days (mean (SD))3/ | 10,27 (7,33) | 10,55 (7,34) | 10,13 (7,35) | 0,556 |